Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-14-034262
Filing Date
2014-10-14
Accepted
2014-10-14 20:26:49
Documents
2
Period of Report
2014-10-06

Document Format Files

Seq Description Document Type Size
1 rrd417580.html 3  
1 rrd417580.xml 3 7356
2 POWER OF ATTORNEY rrd376037_425998.htm EX-24. 2822
  Complete submission text file 0001181431-14-034262.txt   11801
Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY NJ 07054
Business Address
Williams Kristen Marie (Reporting) CIK: 0001296965 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35060 | Film No.: 141156313

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations